1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Neuroproteínas-ictus

Neuroproteínas-ictus

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Chico-Garcia, Juan Luis, Amo, Raquel Sainz, Monreal, Enric, de la Maza, Susana Sainz, Jorge, Fernando Rodriguez, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa Maria.

    Progression independent of relapse activity can be predicted by passively acquired tapping speed through a smartphone for 1 month: A prospective study

    MULTIPLE SCLEROSIS JOURNAL . 30(10): 1239-1349.

    [doi:10.1177/13524585241272960]

  • Sainz de la Maza S, Rodero-Romero A, Monreal E, Chico-García JL, Villarrubia N, Rodríguez-Jorge F, Fernández-Velasco JI, Sainz-Amo R, Costa-Frossard L, Masjuan J, Villar LM.

    COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis.

    Frontiers in immunology . 15: 1439393-1439393.

    [doi:10.3389/fimmu.2024.1439393]

  • Sainz-Amo R, Rodero Romero A, Monreal E, Chico García JL, Fernández Velasco JI, Villarrubia N, Veiga González JL, Sainz de la Maza S, Rodríguez Jorge F, Masjuan J, Costa-Frossard L, Villar LM.

    Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.

    Frontiers in immunology . 15: 1454474-1454474.

    [doi:10.3389/fimmu.2024.1454474]

  • Fernández-Serra R, Lekouaghet A, Peracho L, Yonesi M, Alcázar A, Chioua M, Marco-Contelles J, Pérez-Rigueiro J, Rojo FJ, Panetsos F, Guinea GV, González-Nieto D.

    Permselectivity of Silk Fibroin Hydrogels for Advanced Drug Delivery Neurotherapies.

    Biomacromolecules . 25(8): 5233-5250.

    [doi:10.1021/acs.biomac.4c00629]

  • Rodero-Romero A, Monreal E, Sainz-Amo R, García Domínguez JM, Villarrubia N, Veiga-González JL, Fernández-Velasco JI, Goicochea-Briceño H, Rodríguez-Jorge F, Sainz de la Maza S, Chico-García JL, Muriel A, Masjuan J, Costa-Frossard L, Villar LM.

    Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(14): .

    [doi:10.3390/ijms25147808]

  • Chen CH, Shoamanesh A, Colorado P, Saad F, Lemmens R, De Marchis GM, Caso V, Xu L, Heenan L, Masjuan J, Christensen H, Connolly SJ, Khatri P, Mundl H, Hart RG, Smith EE.

    Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.

    Stroke . 55(6): 1477-1488.

    [doi:10.1161/STROKEAHA.123.045204]

  • Carretero VJ, Liccardi N, Tejedor MA, de Pascual R, Campano JH, Hernández-Guijo JM.

    Lead exerts a depression of neurotransmitter release through a blockade of voltage dependent calcium channels in chromaffin cells.

    Toxicology . 505: 153809-153809.

    [doi:10.1016/j.tox.2024.153809]

  • Chico-Garcia JL, Sainz-Amo R, Monreal E, Rodriguez-Jorge F, Sainz de la Maza S, Masjuan J, Villar LM, Costa-Frossard França L.

    Passive assessment of tapping speed through smartphone is useful for monitoring multiple sclerosis.

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 86: 105595-105595. Nº de citas: 1

    [doi:10.1016/j.msard.2024.105595]

  • Aaron S, Ferreira JM, Coutinho JM, Canhão P, Conforto AB, Arauz A, Carvalho M, Masjuan J, Sharma VK, Putaala J, Uyttenboogaart M, Werring DJ, Bazan R, Mohindra S, Weber J, Coert BA, Kirubakaran P, Sanchez van Kammen M, Singh P, Aguiar de Sousa D, Ferro JM.

    Outcomes of Decompressive Surgery for Patients With Severe Cerebral Venous Thrombosis: DECOMPRESS2 Observational Study.

    Stroke . 55(5): 1218-1226.

    [doi:10.1161/STROKEAHA.123.045051]

  • Scutelnic A, van de Munckhof A, Miraclin AT, Aaron S, Hameed S, Wasay M, Grosu O, Krzywicka K, Sánchez van Kammen M, Lindgren E, Moreira T, Acampora R, Negro A, Karapanayiotides T, Yaghi S, Revert A, Cuadrado Godia E, Garcia-Madrona S, La Spina P, Grillo F, Giammello F, Nguyen TN, Abdalkader M, Buture A, Sofia Cotelli M, Raposo N, Tsivgoulis G, Candelaresi P, Ciacciarelli A, Mbroh J, Batenkova T, Scoppettuolo P, Zedde M, Pascarella R, Antonenko K, Kristoffersen ES, Kremer Hovinga JA, Jood K, Aguiar de Sousa D, Poli S, Tatlisumak T, Putaala J, Coutinho JM, Ferro JM, Arnold M, Heldner MR.

    Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19.

    European Stroke Journal . : .

    [doi:10.1177/23969873241241885]

  • Escobar-Peso A, Martínez-Alonso E, Hadjipavlou-Litina D, Alcázar A, Marco-Contelles J.

    Synthesis, antioxidant and neuroprotective analysis of diversely functionalized a-aryl-N-alkyl nitrones as potential agents for ischemic stroke therapy.

    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY . 266: 116133-116133. Nº de citas: 1

    [doi:10.1016/j.ejmech.2024.116133]

  • Smith EE, Shoamanesh A, Xu L, Heenan L, Saad F, Colorado P, Chen CH, Lemmens R, De Marchis GM, Caso V, Masjuan J, Hirano T, Milanov I, Campbell BCV, Mas JL, Connolly SJ, Mundl H, Hart RG.

    Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.

    Stroke . 55(2): 392-402.

    [doi:10.1161/STROKEAHA.123.043198]

  • García-Alberca JM, de Rojas I, Sanchez-Mejias E, Garrido-Martín D, Gonzalez-Palma L, Jimenez S, Pino-Angeles A, Cruz-Gamero JM, Mendoza S, Alarcón-Martín E, Muñoz-Castro C, Real LM, Tena JJ, Polvillo R, Govantes F, Lopez A, Royo-Aguado JL, Navarro V, Gonzalez I, Ruiz M, Reyes-Engel A, Gris E, Bravo MJ, Lopez-Gutierrez L, Mejias-Ortega M, De la Guía P, López de la Rica M, Ocejo O, Torrecilla J, Zafra C, Nieto MD, Urbano C, Jiménez-Sánchez R, Pareja N, Luque M, García-Peralta M, Carrillejo R, Furniet MDC, Rueda L, Sánchez-Fernández A, Mancilla T, Peña I, García-Casares N, Moreno-Grau S, Hernández I, Montrreal L, Quintela I, González-Pérez A, Calero M, Franco-Macías E, Macías J, Menéndez-González M, Frank-García A, Huerto Vilas R, Diez-Fairen M, Lage C, García-Madrona S, García-González P, Valero S, Sotolongo-Grau O, Pérez-Cordón A, Rábano A, Arias Pastor A, Pastor AB, Espinosa A, Corma-Gómez A, Martín Montes Á, Sanabria Á, Martínez Rodríguez C, Buiza-Rueda D, Rodriguez-Rodriguez E, Ortega G, Alvarez I, Rosas Allende I, Pineda JA, Rosende-Roca M, Bernal Sánchez-Arjona M, Fernández-Fuertes M, Alegret M, Roberto N, Del Ser T, Garcia-Ribas G, Sánchez-Juan P, Pastor P, Piñol-Ripoll G, Bullido MJ, Álvarez V, Mir P, Medina M, Marquié M, Sáez ME, Carracedo Á, Laplana M, Tomas-Gallardo L, Orellana A, Tárraga L, Boada M, Fibla Palazon J, Vitorica J, Ruiz A, Guigo R, Gutierrez A, Royo JL.

    An Insertion Within SIRPß1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.

    JOURNAL OF ALZHEIMERS DISEASE . 98(2): 601-618.

    [doi:10.3233/JAD-231150]

  • Escobar-Peso A, Martínez-Alonso E, Masjuan J, Alcázar A.

    Development of Pharmacological Strategies with Therapeutic Potential in Ischemic Stroke.

    ANTIOXIDANTS . 12(12): .

    [doi:10.3390/antiox12122102]

  • Bernal-Rubio L, Martínez-Alonso E, Fernández-Lozano C, Sola-Martínez FJ, Martínez-Botas J, Alcázar A, De la Hoz-Caballer B.

    Identification of alpha-L-fucosidase protein as the possible responsible of cardamom food allergy.

    Journal of investigational allergology & clinical immunology . 34(3): 0-0.

    [doi:10.18176/jiaci.0957]

  • Monreal E, Fernández-Velasco JI, García-Soidán A, Sainz de la Maza S, Espiño M, Villarrubia N, Rodríguez-Jorge F, Chico-García JL, Sainz-Amo R, Masjuan J, Costa-Frossard L, Villar LM.

    Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.

    Frontiers in immunology . 14: 1288169-1288169.

    [doi:10.3389/fimmu.2023.1288169]

  • Carretero VJ, Ramos E, Segura-Chama P, Hernández A, Baraibar AM, Álvarez-Merz I, Muñoz FL, Egea J, Solís JM, Romero A, Hernández-Guijo JM.

    Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging.

    ANTIOXIDANTS . 12(10): .

    [doi:10.3390/antiox12101844]

  • Álvarez-Merz I, Muñoz MD, Hernández-Guijo JM, Solís JM.

    Identification of Non-excitatory Amino Acids and Transporters Mediating the Irreversible Synaptic Silencing After Hypoxia

    TRANSLATIONAL STROKE RESEARCH . : . Nº de citas: 1

    [doi:10.1007/s12975-023-01192-y]